Emergence of a virulent new meningococcal W sequence type 11 in South America: experience, control measures and impact
http://www.meningitis.org/conference2015
Current epidemiology of meningococcal disease in the African meningitis belt and new WHO outbreak response guidelines after the Meningitis Vaccine Project
http://www.meningitis.org/conference2015
Emergence of a virulent new meningococcal W sequence type 11 in South America: experience, control measures and impact
http://www.meningitis.org/conference2015
Current epidemiology of meningococcal disease in the African meningitis belt and new WHO outbreak response guidelines after the Meningitis Vaccine Project
http://www.meningitis.org/conference2015
Single-dose oral ciprofloxacin prophylaxis as a meningococcal meningitis outbreak response: results of a cluster-randomized trial
https://www.meningitis.org/mrf-conference-2017
Professor Michael Levin's presentation at Meningitis Research Foundation's 2013 conference Meningitis & Septicaemia in Children & Adults www.meningitis.org/conference2013
Novartis satellite breakfast session at the Meningitis Research Foundation 2013 conference, Meningitis & Septicaemia in Children & Adults presented by Emeritus Professor Richard Moxon, Dr Jamie Findlow and Dr Simon Nadel
Preparedness for and response to meningococcal outbreaks: preliminary results of a Canadian Immunization Research Network (CIRN) randomized controlled trial of two schedules of 4CMenB vaccine in adolescents and young adults.
https://www.meningitis.org/mrf-conference-2017
Meningococcal carriage in the African meningitis belt and the impact of MenAfriVac: an overview of the MenAfriCar project
http://www.meningitis.org/conference2015
Single-dose oral ciprofloxacin prophylaxis as a meningococcal meningitis outbreak response: results of a cluster-randomized trial
https://www.meningitis.org/mrf-conference-2017
Professor Michael Levin's presentation at Meningitis Research Foundation's 2013 conference Meningitis & Septicaemia in Children & Adults www.meningitis.org/conference2013
Novartis satellite breakfast session at the Meningitis Research Foundation 2013 conference, Meningitis & Septicaemia in Children & Adults presented by Emeritus Professor Richard Moxon, Dr Jamie Findlow and Dr Simon Nadel
Preparedness for and response to meningococcal outbreaks: preliminary results of a Canadian Immunization Research Network (CIRN) randomized controlled trial of two schedules of 4CMenB vaccine in adolescents and young adults.
https://www.meningitis.org/mrf-conference-2017
Meningococcal carriage in the African meningitis belt and the impact of MenAfriVac: an overview of the MenAfriCar project
http://www.meningitis.org/conference2015
Dr Alison Young, Consultant Medical Oncology, Leeds Teaching Hospitals Trust
Dr Andrew Stewart, Haematologist and Lead for Acute Oncology, University Hospitals of the North Midlands
Ceri Stubbs, Clinical Lead, Velindre NHS Trust
How health analytics are changing the way we understand and manage healthcare. Presented by Professor Enrico Coiera, Faculty of Medicine at the University of NSW, Australia, at HINZ 2014, 11 November 2014, 10am, Plenary Room
Presentation slides from our first meeting, held on Tuesday 10th September 2013 at the Royal College of Surgeons.
Find us on
Twitter @STARSurgUK
Facebook.com/STARSurgUK
Email: STARSurgUK@gmail.com
Challenges and Considerations in Designing and Conducting Immuno-Oncology Cli...Medpace
Given the accelerating pace of immuno-oncology clinical research, awareness of the specific challenges and considerations in designing and conducting successful trials for these new agents is critical.
WHO Italian CME course an antibiotic stewardship
• Understand the frequent occurrence and implications of
contaminated urine cultures and of asymptomatic bacteriuria
• Illustrate the complexity of using urinalysis and urine culture to
support the diagnosis of urinary tract infections
• Demonstrate the use of local evidence-based guidelines based
upon local antimicrobial resistance data in managing urinary tract infections
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
NVBDCP.pptx Nation vector borne disease control program
Dr Fiona McGill @ MRF's Meningitis & Septicaemia in Children & Adults 2015
1. The UK Joint Specialist Societies Guideline on
the Diagnosis and Management of Acute
Meningitis and Meningococcal sepsis in
immunocompetent adults.
Fiona McGill, RS Heyderman, BD Michael, S Defres, NJ
Beeching, R Borrow, A Miller, L Glennie, O Gaillemin, D
Wyncoll, E Kaczmarski, S Nadel, G Thwaites, J Cohen,
NWS Davies, A Rhodes, R Read, T Solomon
British Infection Association
Public Health England
Intensive Care Society
Association of British Neurologists
Society for Acute Medicine
Meningitis Research Foundation
5. Why do we need a guideline?
The management of meningitis in the UK is sub-
optimal
• Published UK based audits:
– Specific diagnostic tests (beyond culture) often
omitted e.g. molecular tests
– Considerable variability in dosage of antibiotics
prescribed
– Delays in antibiotics and investigations
– Inappropriate tests e.g. CT scans
Cullen; Journal of Infection 2005
Stockdale; Quarterly Medical Journal 2011
6. Guidelines may improve outcomes
– Swedish national review after guideline revision
• Treatment started earlier
• Mortality reduced
– US study comparing 3 time periods
• Mortality decreased
• “associated with the introduction of recommendations for
use of adjunctive dexamethasone for pneumococcal
meningitis”
– Dutch historical cohort comparison
• Improved outcome and mortality
• Follows recommendations for steroids Glimaker; Clinical Infectious Diseases 2015
Castelblanco; Lancet Infectious Diseases 2014
Brouwer; Neurology 2010
7. Our aims:
• to create user-friendly, comprehensive,
evidence-based guidelines primarily for
hospital-based clinicians in the UK with
auditable outcomes.
• Scope:
– Adults
– suspected and proven acute meningitis and
meningococcal sepsis
– pre-hospital care to post-discharge support
8. Fiona: “when will the meningitis guidelines be
revised?”
BIA guidelines secretary “Would you like to do it?”
1999
2003
2012
9. Methods
• Working party formed
• Identified questions
• Literature search
• 2-3 authors wrote each section
• Whole guideline assimilated and edited
• Consultation with stakeholders
– Revision and editing
10. Methods
• Working party formed
• Identified questions
• Literature search
• 2-3 authors wrote the relevant section
• Whole guideline assimilated and edited
• Consultation with stakeholders
– Revision and editing
12. Key Recommendations
• Pre-hospital management
• Indications for hospital admission
• Clinical signs
• Pre admission antibiotics
• Initial hospital assessment
• Neuroimaging and lumbar
punctures
• Bleeding risks and lumbar
punctures
• Diagnostic Scoring systems
• Investigations
• Treatment
• Empirical
• Definitive
• Adjunctive
• Outpatient treatment
• Critical Care
• Which patients should be
referred to critical care
• Other critical care management
issues
• Prophylaxis
• Prevention of secondary cases
• Screening for predispositions
• Infection control measures
• Follow Up/Sequelae
• Viral Meningitis
• Audit Tool
13. Key Recommendations
• Pre-hospital management
• Indications for hospital admission
• Clinical signs
• Pre admission antibiotics
• Initial hospital assessment
• Neuroimaging and lumbar
punctures
• Bleeding risks and lumbar
punctures
• Diagnostic Scoring systems
• Investigations
• Treatment
• Empirical
• Definitive
• Adjunctive
• Outpatient treatment
• Critical Care
• Which patients should be
referred to critical care
• Other critical care management
issues
• Prophylaxis
• Prevention of secondary cases
• Screening for predispositions
• Infection control measures
• Follow Up/Sequelae
• Viral Meningitis
• Audit Tool
14. Antibiotics in the community
• Give to those who have signs of
meningococcal disease, severe sepsis or
where there might be a delay in getting to
hospital
• Patients with known anaphylaxis should not
receive antibiotics in the community
15. Initial hospital assessment
• Action to be taken within the first hour of
arriving in hospital
– Stabilisation of patient
– Blood cultures taken
– Lumbar puncture if safe (patients with meningitis)
– Treatment commenced
– Fluid resuscitation (if signs of sepsis)
– Document decision regarding senior review and
need for critical care input
16. Medical training
• All clinicians managing patients should have
training on the initial management of acute
bacterial meningitis and meningococcal sepsis
• Patients should be cared for with the input of
an infection specialist
17. Neuroimaging and Lumbar Puncture
Image courtesy of Dr Andrew Dixon, Radiopaedia.org, rID: 32383
Image courtesy of Dr Benedict Michael.
18. Associations between performing CT scans and:
• delays in antibiotics and LP,
• worse outcome,
• decreased chance of identifying organism
Proulx; Quaterly Journal of Medicine 2005
Michael; Emergency Medical Journal 2010
Glimaker; Clinical Infectious Diseases 2015
All (n=1117) Had CT
(n=901)
Did not have CT
(n=216)
P value
Time from admission to
LP, median hours (IQR)
16 (6.75,28) 18 (8,29) 10 (4,22) <0.001
Time from admission to
antibiotics, median
hours (IQR)
3 (1,11) 3 (1,11) 2 (0,10) 0.002
McGill et al, unpublished, UK Meningitis Study
19. Which patients need a CT scan?
Indications for neuroimaging prior to LP in suspected meningitis*
Focal neurological signs
Presence of papilloedema**
Continuous or uncontrolled seizures
GCS ≤12***
*to exclude significant brain swelling and shift that may predispose
to cerebral herniation post LP
**inability to view the fundus is not a contraindication to LP,
especially in patients who have had a short duration of symptoms
*** LP may be safe at levels below this
20. Bleeding risk and LPs
• Delay LMWH until after
LP is performed
• INR<=1.4
• Platelets >40
• LP should not be
delayed for the results
of blood tests unless a
high clinical suspicion
of a bleeding diathesis
• Other reasons to delay
LP:
• Infection at site of LP
• Unstable patient
• Haemodynamic/respiratory
compromise
21. Meningitis Suspected Meningococcal Sepsis
Bloods Blood Cultures
FBC, Urea, creatinine and electrolytes,
LFT’s, clotting screen, Lactate
Procalcitonin (or CRP if unavailable)
Meningococcal and Pneumococcal PCR
Serology sample
Glucose
HIV Ab/Ag test
CSF Cell Count
Opening Pressure
Microscopy, Culture and Sensitivity
Meningococcal and Pneumococcal PCR
Protein, Glucose, Lactate
Throat swab Bacterial CultureBacterial Culture
Further tests (if no aetiology identified on first panel)
If bacterial meningitis seems likely:
16S rRNA PCR on CSF
If viral meningitis seems likely:
CSF PCR for:
HSV 1, HSV 2, VZV and Enterovirus.
Stool for Enterovirus PCR
Throat swab for Enterovirus PCR
Blood Cultures
FBC, Urea, creatinine and electrolytes,
LFT’s, clotting screen, Lactate
Procalcitonin (or CRP if unavailable)
Meningococcal and Pneumococcal PCR
Serology sample
Glucose
HIV Ab/Ag test
Investigations
22. Empirical Treatment
– Ceftriaxone/Cefotaxime
– Think about penicillin resistance if recent travel – add
in IV Vancomycin or Rifampicin
– Add in Amoxicillin if >60 or immunocompromised
– Chloramphenicol if anaphylaxis to
penicillins/cephalosporins
23. Definitive treatment
• Guided by microbiological results
– Continue cephalosporin or de-escalate to Benzylpenicillin
• Consider outpatient therapy
• Aciclovir/valaciclovir not recommended in herpes meningitis
Duration of treatment
Pneumococcal Meningitis
Good Recovery 10 days
Delayed Recovery 14 days
Meningococcal Meningitis/Sepsis
Good recovery 5 days
Delayed Recovery 7 days
No identified pathogen
Good recovery 10 days
Delayed recovery 14 days
24. Adjunctive treatment
• Dexamethasone 10mg IV 6 hourly
– can be given up to 12 hours after antibiotics
• No role for glycerol or therapeutic
hypothermia
25. Critical Care
• Involve early
• Refer
– Those with rapidly evolving rash
– Those with GCS of 12 or less
– Those requiring monitoring or organ support
– Those with uncontrolled seizures
• Intubation strongly considered in those with GCS of
12 or less
• Anyone with severe sepsis should be managed in a
critical care setting
26. Prophylaxis/screening
• All patients with meningitis or meningococcal
sepsis should have an HIV test
• Patients with 2 or more episodes (or family
history of > 1) should have immunological
investigations
• Trauma, neurosurgery or rhino/otorrhoea –
investigations for a CSF leak
27. Follow up/sequelae
• Follow up appointments
• Hearing tests within 4 weeks of being well
enough to test
• Fast track assessment for cochlear implant
• Support organisations
29. Implementation
• How do we actually get people to use the guideline?
• How do we assess the effectiveness or otherwise of
the guideline?
• Implementation best achieved with a multifaceted
approach actively engaging clinicians (Prior; J Eval Clin Pract, 2008)
More effective interventions Less effective interventions
Multifaceted interventions Didactic education
Interactive education Passive dissemination
strategies
Clinical reminder systems
30. Many doctors unaware of the existence of the guidelines
“I know there are guidelines, but and I know that you could
probably just Google them and they would probably just be there
erm... It is ringing some bells but I couldn't tell you what was on it
((laughs)).” ST3 elderly care
“Erm... there must be some national guidelines, and I do actually
need to read them, I have not read any recently erm...“
ST3 gasteroenterology
“Erm… well I know there are some but I don’t, I have never used
them.” CT1 Acute Medicine/ A and E
“Yes, I mean I… I have done you know I have done a fair amount of
emergency medicine and acute medicine and it [the use of steroids
in the management of meningitis] is not something I have really
come across, but then how many actual proper bacterial
meningitises have I seen.” CT1 Acute Medicine/A and E
31. How do we actually get people to use
the guideline?
• They need to have heard
about it
– National launch
• Federation of Infection
Societies Conference
– Involvement of several
societies
• Presentations at Intensive
Care Society meeting in
December
• Write up in the Society for
Acute Medicine’s journal
– Algorithm
– Audit Tool
32. How do we actually get people to use
the guideline?
• Some other suggestions (for discussion…)
– National audit
– Press release
– Editorial
– Apps/easy to navigate ‘clickable’ electronic versions
– Learning modules - BMJ learning
33. How do we assess the effectiveness or
otherwise of the guideline?
• Audit Tool
– National audit
• Historical cohort studies
• Other suggestions welcome
34. Acknowledgements
• All authors
• All members of the partner organisations for
comments in the consultation period
• Dr Huw Cooper and Professor C H Raine for
advice regarding audiological follow up
Editor's Notes
Probably don’t need to tell this audience about the cases of poor management of meningitis that make the news. And although these extreme cases are thankfully rare there is definitely room for improvement across the board in the management of meningitis.
Couple of published audits in the UK
354 minutes = almost 6 hours
Over 3 hours
At least 3 large nationwide studies claiming improvements following changes in guideline recommendations
Numerous biases, not least we don’t know how well the guidelines were adhered to, but there is a suggestion of improvement….
Glimaker attributes the changes to the removal of reduced conscious level as a contraindication to LP’; castelblanco and brouwer suggest recommendations regarding steroids are responsible for the changes seen
including clinical features, investigations, treatment, follow-up and prevention.
Not TB, neurosurgical, paedicatric
Many people/doctors are aware of the algorithm – few are aware of the original consensus statement. Possible over the last 15 years clinical guidelines have become much more commonplace and one reason for updating the guidelines would be to make them more user friendly and more widely known.
In 2011 I started work at the LBIG on a study, funded by the MRF, looking at outcomes and epidemiology of menignitis – mainly viral but hey. I was also on the council for the British Infection Association. Those two things conspired and an innocent question at a steering committee about when the meningitis guidelines would be revised resulted in this mammoth task ahead of us – 3 years later this is what we have……
BIA, SAM, ICS, MRF, ABN, PHE
BIA, SAM, ICS, MRF, ABN, PHE
Not going to go through all 121 recommendations………some where there are changes
Grading is given in the guideline
Minimal RCT evidence, much of it is based on observational studies, if not even observational studies some things are graded ‘author recommendation’.
Not going to go through all 121 recommendations…
Going to go through the ones that are new, have changed or might be contraversial
More in line with the paediatric guidance,
Minimal evidence regarding abx in community
Not recommended in other forms of infection/sepsis
Focus on early senior review/critical care involvement
Focus on the first hour – compromise between what is good practice and what is practically achievable. Changing cultures.
Hopefully a call for hospitals to ensure meningitis is part of compulsory teaching programmes
A couple of studies showing patients that are looked after on an ID ward do better plus lots of anecdotal evidence….
Concern regarding the risk of cerebral herniation
The risk attributable to LP is not clear
Bacterial meningitis itself causes herniation (even in the absence of LP)
Risk is probably higher if there is evidence of ‘brain shift’, often associated with space occupying lesion
Benefits of LP – establishing a diagnosis, antimicrobial sensitivities –need to be weighed against the potential risks
CT head is NOT performed to identify raised intracranial pressure
An LP is NOT contraindicated in the presence of raised intracranial pressure – in fact is often used therapeutically in those situations (e.g. cryptococcal meningitis)
Glimaker – compared with CT before LP
Only 5 of these patients had proven bacterial meningitis (out of 301)
In an attempt to reduce the number of unnecessary CT scans and potentially improve the measures quoted before we have rationalised the recommendations for CT scanning to those that might indicate a space occupying lesion. There are other contraindications to immediate LP. Removal of immunocompromise, stress it is the presence of papilloedema and not the inability to see the fundus that is a contraindication, GCS - ? Still quite high but this was a compromise between what would clinicians would be comfortable with.
Limited data in meninigitis, extrapolated from data in anaesthetics, obstetrics and oncology with caveats that these do not necessarily have the same risks.
Not much too different, stressed the possibility of pen resistance and inserted a couple of websites regarding european and global risks of PRP.
Age cut off for listeria is slightly higher and added in other risk factors such as DM, alcohol excess etc…
Attempted to make this section flow as you would get the results so what to do if the gram film shows something, culture or PCR etc…..
Durations have been reduced slightly and made more definitive – it was felt that 10-14 days was not helpful. 10 days if doing well or 14 if not. 5 and 7 for meningococcal.
OPAT – this is new, increasing reports of treating meningitis as an outpatient – especially uncomplicated meningococcal or the end of a course for oneumococcal.
More pragmatic recommendation for Dex – dose as per the original de Gans Dutch trial. In practice steroids are rarely given with or before abx and so it was felt necessary to allow a period of time after the abx had been given. A sub group analysis of the most recent cochrane review showed that there was no difference beween patients who received steroids after abx compared with those who received them before or with. Exact timings of when steroids were given varied between studies and so 12 hours was chosen as a pragmatic time point.
again, emphasis on early referral
Meningitis = CSF pleocytosis
Institgated by an immunologist/infection specialist
Not all sequelae will be apparent on discharge
Follow up for all patients with bacterial meningitis recognising that not all sequelae will be apparent on discharge
If hearing loss reported rapid hearing assessment
If documentation of significant hearing loss – fast track for cochlear implant